Loading company…
Synthon makes complex generic medicines, with a focus on oncology products such as abiraterone and anastrozole tablets.
Founded in 1991 and headquartered in Nijmegen, Netherlands, Synthon is led by CEO Anish Mehta. In December 2024 Goldman Sachs Asset Management and GIC agreed to acquire a majority stake from BC Partners for approximately EUR 2.1 billion. The company sells to hospitals, pharmacies and healthcare providers in the US, Europe and Latin America, and holds an exclusive license for Palbociclib Tablets in the US market.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in